141 related articles for article (PubMed ID: 12765990)
1. Preanalytical factors that influence the Abbott TDx Fetal Lung Maturity II assay.
Grenache DG; Parvin CA; Gronowski AM
Clin Chem; 2003 Jun; 49(6 Pt 1):935-9. PubMed ID: 12765990
[TBL] [Abstract][Full Text] [Related]
2. Use of the TDx-FLM assay in evaluating fetal lung maturity in an insulin-dependent diabetic population. The Diabetes and Fetal Maturity Study Group.
Livingston EG; Herbert WN; Hage ML; Chapman JF; Stubbs TM
Obstet Gynecol; 1995 Nov; 86(5):826-9. PubMed ID: 7566857
[TBL] [Abstract][Full Text] [Related]
3. Gestational age-specific predicted risk of neonatal respiratory distress syndrome using lamellar body count and surfactant-to-albumin ratio in amniotic fluid.
Karcher R; Sykes E; Batton D; Uddin Z; Ross G; Hockman E; Shade GH
Am J Obstet Gynecol; 2005 Nov; 193(5):1680-4. PubMed ID: 16260210
[TBL] [Abstract][Full Text] [Related]
4. Gestational age-specific cutoff levels of TDx-FLM II for the prediction of neonatal respiratory distress syndrome.
Bennasar M; Figueras F; Palacio M; Bellart J; Casals E; Figueras J; Coll O; Gratacós E
Fetal Diagn Ther; 2009; 25(4):392-6. PubMed ID: 19786785
[TBL] [Abstract][Full Text] [Related]
5. Validation of lamellar body counts using three hematology analyzers.
Lockwood CM; Crompton JC; Riley JK; Landeros K; Dietzen DJ; Grenache DG; Gronowski AM
Am J Clin Pathol; 2010 Sep; 134(3):420-8. PubMed ID: 20716798
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the diagnostic accuracy of the TDx-FLM II to predict fetal lung maturity.
Fantz CR; Powell C; Karon B; Parvin CA; Hankins K; Dayal M; Sadovsky Y; Johari V; Apple FS; Gronowski AM
Clin Chem; 2002 May; 48(5):761-5. PubMed ID: 11978603
[TBL] [Abstract][Full Text] [Related]
7. Role of the TDx FLM assay in fetal lung maturity.
Herbert WN; Chapman JF; Schnoor MM
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):808-12. PubMed ID: 8456885
[TBL] [Abstract][Full Text] [Related]
8. Interpretation of the TDx-FLM fluorescence polarization assay in pregnancies complicated by diabetes mellitus.
Del Valle GO; Adair CD; Ramos EE; Gaudier FL; Sanchez-Ramos L; Morales R
Am J Perinatol; 1997 May; 14(5):241-4. PubMed ID: 9259935
[TBL] [Abstract][Full Text] [Related]
9. Comparison of infrared spectroscopic and fluorescence depolarization assays for fetal lung maturity.
Liu KZ; Shaw RA; Dembinski TC; Reid GJ; Ying SL; Mantsch HH
Am J Obstet Gynecol; 2000 Jul; 183(1):181-7. PubMed ID: 10920328
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the accuracy of the TDx-FLM assay, lecithin-sphingomyelin ratio, and phosphatidylglycerol in the prediction of neonatal respiratory distress syndrome.
Hagen E; Link JC; Arias F
Obstet Gynecol; 1993 Dec; 82(6):1004-8. PubMed ID: 8233250
[TBL] [Abstract][Full Text] [Related]
11. Prediction of respiratory distress syndrome using the Abbott FLM-II amniotic fluid assay.
Kaplan LA; Chapman JF; Bock JL; Santa Maria E; Clejan S; Huddleston DJ; Reed RG; Bernstein LH; Gillen-Goldstein J
Clin Chim Acta; 2002 Dec; 326(1-2):61-8. PubMed ID: 12417097
[TBL] [Abstract][Full Text] [Related]
12. Prediction of fetal lung maturity in infants of diabetic mothers using the FLM S/A and disaturated phosphatidylcholine tests.
Tanasijevic MJ; Winkelman JW; Wybenga DR; Richardson DK; Greene MF
Am J Clin Pathol; 1996 Jan; 105(1):17-22. PubMed ID: 8561082
[TBL] [Abstract][Full Text] [Related]
13. The usefulness of the TDx/TDxFLx fetal lung maturity II assay in the initial evaluation of fetal lung maturity.
Kesselman EJ; Figueroa R; Garry D; Maulik D
Am J Obstet Gynecol; 2003 May; 188(5):1220-2. PubMed ID: 12748484
[TBL] [Abstract][Full Text] [Related]
14. Predicting respiratory distress syndrome using gestational age and fetal lung maturity by fluorescent polarization.
Parvin CA; Kaplan LA; Chapman JF; McManamon TG; Gronowski AM
Am J Obstet Gynecol; 2005 Jan; 192(1):199-207. PubMed ID: 15672025
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of two-dimensional cytometric lamellar body counts on the ADVIA 120 hematology system for estimation of fetal lung maturation.
Chapman JF; Ashwood ER; Feld R; Wu AH
Clin Chim Acta; 2004 Feb; 340(1-2):85-92. PubMed ID: 14734199
[TBL] [Abstract][Full Text] [Related]
16. Rapid fetal lung maturity testing: commercial versus NBD-phosphatidylcholine assay.
Ashwood ER; Palmer SE; Lenke RR
Obstet Gynecol; 1992 Dec; 80(6):1048-53. PubMed ID: 1448250
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the TDx-FLM II and lecithin to sphingomyelin ratio assays in predicting fetal lung maturity.
Winn-McMillan T; Karon BS
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):778-82. PubMed ID: 16150274
[TBL] [Abstract][Full Text] [Related]
18. Measurement of amniotic fluid surfactant.
Freer DE; Statland BE
Clin Chem; 1981 Oct; 27(10):1629-41. PubMed ID: 6269778
[TBL] [Abstract][Full Text] [Related]
19. Bilirubin in amniotic fluid does not interfere with the Abbott TDx FLM II assay.
Cariappa R; Parvin CA; Gronowski AM
Clin Chem; 2003 Jun; 49(6 Pt 1):986-7. PubMed ID: 12766006
[No Abstract] [Full Text] [Related]
20. The effect of maternal blood contamination on the TDx-FLM II assay.
Carlan SJ; Gearity D; O'Brien WF
Am J Perinatol; 1997 Sep; 14(8):491-4. PubMed ID: 9376013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
